Covered recipient · General Payments record
DANIEL J GOLDSTEIN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$512.17
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $247.01 | 8 |
| Education | $22.65 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $109.14 | 1 |
| Lundbeck LLC | $42.41 | 2 |
| Acerta Pharma LLC | $38.60 | 2 |
| Edwards Lifesciences Corporation | $25.00 | 1 |
| Novo Nordisk AS | $24.80 | 1 |
| Abbott Laboratories | $16.29 | 1 |
| Lilly USA, LLC | $13.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.29 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124933148 | CMS |
| Amgen Inc. | $109.14 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585822 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.11 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105500076 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.49 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105561030 | CMS |
| Edwards Lifesciences Corporation | $25.00 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138861801 | CMS |
| Lilly USA, LLC | $13.42 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136120962 | CMS |
| Lundbeck LLC | $19.76 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145919521 | CMS |
| Lundbeck LLC | $22.65 | 09/10/2024 | Education | Undisputed | 01/23/2026 | 1145919523 | CMS |
| Novo Nordisk Inc | $24.80 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096875657 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.